Title : Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.

Pub. Date : 2009 Aug 10

PMID : 19470933






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 Abiraterone acetate is a potent, selective, and orally available inhibitor of CYP17, the key enzyme in androgen and estrogen biosynthesis. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens
3 CONCLUSION: CYP17 blockade by abiraterone acetate results in declines in PSA and CTC counts and radiologic responses, confirming that CRPC commonly remains hormone driven. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens